Your browser doesn't support javascript.
loading
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model.
Li, Chang; Wang, Hongjie; Georgakopoulou, Aphrodite; Gil, Sucheol; Yannaki, Evangelia; Lieber, André.
Afiliação
  • Li C; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA.
  • Wang H; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA.
  • Georgakopoulou A; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA; Gene and Cell Therapy Center, Hematology Department, George Papanicolaou Hospital, Thessaloniki 57010, Greece.
  • Gil S; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA.
  • Yannaki E; Gene and Cell Therapy Center, Hematology Department, George Papanicolaou Hospital, Thessaloniki 57010, Greece.
  • Lieber A; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA; Department of Pathology, University of Washington, Seattle, WA 98195, USA. Electronic address: lieber00@uw.edu.
Mol Ther ; 29(2): 822-837, 2021 02 03.
Article em En | MEDLINE | ID: mdl-32949495

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Terapia Genética / Adenoviridae / Transplante de Células-Tronco Hematopoéticas / Vetores Genéticos / Anemia Falciforme Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Terapia Genética / Adenoviridae / Transplante de Células-Tronco Hematopoéticas / Vetores Genéticos / Anemia Falciforme Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article